Receptos Pharmaceuticals Obtains $25,000,000 Series A Financing

  • Feed Type
  • Date
    11/23/2009
  • Company Name
    Receptos Pharmaceuticals
  • Mailing Address
    10835 Road to the Cure San Diego, CA 92121
  • Company Description
    Receptos is developing the next generation in GPCR drug discovery.
  • Website
    http://www.receptos.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $25,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The Series A capital will support the company’s lead sphingosine-1-phosphate receptor 1 (S1P1) clinical candidate through Phase 1 human clinical trials, development of a second IND candidate, as well as the select partnering of the proprietary technology platform for GPCR drug discovery and development.
  • M&A Terms
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    Lilly Ventures
  • Venture Investor
    Venrock

By posting a comment, you agree to our terms and conditions.